The Physician Who Wrote China's Integrative Liver Cancer Guidelines
When China's medical authorities needed to establish the national standard for integrative Traditional Chinese Medicine and Western medicine treatment of primary liver cancer, they turned to the team at Changhai Hospital's TCM Oncology Department. Dr. Zhai Xiaofeng — Director of TCM Oncology at Changhai Hospital — was the lead author of the resulting "Guidelines for Integrative TCM-Western Medicine Diagnosis and Treatment of Primary Liver Cancer" — the document that now defines best practice for integrative liver cancer treatment across China.
Featured Specialist: Dr. Zhai Xiaofeng
Dr. Zhai Xiaofeng is Director of the Department of TCM Oncology at Changhai Hospital, Naval Medical University (Haijun Junyi Daxue Fushu Changhai Yiyuan). He works alongside Prof. Ling Changquan — National Famous TCM Physician and creator of the Cancer Toxin theory — in one of China's most distinguished TCM oncology departments.
Dr. Zhai's defining achievement:
- Lead author of the "Guidelines for Integrative TCM-Western Medicine Diagnosis and Treatment of Primary Liver Cancer" — the national standard document that codifies how integrative TCM-Western medicine treatment should be practiced for liver cancer across China
- Long-term dedication to integrative TCM-Western medicine diagnosis and treatment of hepatobiliary malignancies — spanning liver cancer (HCC), intrahepatic cholangiocarcinoma, gallbladder cancer, and bile duct cancer
- Deep clinical expertise accumulated over years of specialized practice in one of China's most active liver cancer centers
What the Guidelines Mean for Patients
The fact that Dr. Zhai authored the national integrative liver cancer guidelines has direct implications for patients who consult him:
- He has the most comprehensive knowledge of the evidence base for integrative liver cancer treatment — having reviewed and synthesized all available clinical research to write the guidelines
- His treatment recommendations reflect not just personal clinical experience but the collective judgment of China's leading hepatology and TCM oncology experts
- He is aware of the boundaries of evidence — where TCM has strong clinical trial support, where it has observational evidence, and where it is based on expert consensus — enabling honest, calibrated recommendations
- His protocols are the ones that other integrative oncologists across China are now following
Hepatobiliary Malignancies: Dr. Zhai's Scope of Practice
Dr. Zhai's integrative expertise extends across the full spectrum of hepatobiliary cancers:
Hepatocellular Carcinoma (HCC / Liver Cancer)
- Integrative treatment at all stages — early, intermediate, advanced, and recurrent
- TCM support alongside surgery, TACE, ablation, HAIC, targeted therapy, and immunotherapy
- Recurrence prevention protocols after curative treatment
- Symptom management and quality of life support for advanced disease
Intrahepatic Cholangiocarcinoma (ICC)
- Primary bile duct cancer arising within the liver — a rare and aggressive malignancy with limited Western treatment options
- TCM support alongside gemcitabine-cisplatin chemotherapy and targeted therapy (FGFR inhibitors, IDH1 inhibitors)
- Symptom management: jaundice, fatigue, pain, and appetite loss
Gallbladder Cancer
- TCM support alongside surgery, chemotherapy, and radiation
- Management of biliary obstruction symptoms
- Constitutional strengthening for patients with poor performance status
Hilar Cholangiocarcinoma (Klatskin Tumor)
- TCM support for patients undergoing complex biliary reconstruction surgery
- Post-operative recovery and immune reconstitution
- Palliative symptom management for unresectable disease
The Changhai Hospital TCM Oncology Department
Dr. Zhai leads the TCM Oncology Department at Changhai Hospital alongside Prof. Ling Changquan — creating a department with unparalleled depth of expertise in integrative liver cancer treatment:
- Prof. Ling Changquan: National Famous TCM Physician, National Distinguished Young Scholar, creator of the Cancer Toxin theory, whose integrative protocol is incorporated into the National Primary Liver Cancer Guidelines
- Dr. Zhai Xiaofeng: Department Director, lead author of the Integrative TCM-Western Medicine Liver Cancer Guidelines
Together, they represent the most authoritative integrative liver cancer TCM program in China — combining theoretical innovation with guideline-level clinical evidence.
How CMCS Coordinates Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading integrative oncology specialists, including Dr. Zhai Xiaofeng at Changhai Hospital, and manage every step of the process:
- Review of existing Western treatment records, liver function tests, imaging, and current medications for herb-drug interaction screening
- Consultation scheduling with Dr. Zhai's TCM oncology team
- Coordination with hepatobiliary surgery, interventional oncology, and medical oncology teams for integrated planning
- Medical interpretation during TCM consultations
- Guidance on herbal medicine preparation and administration for international patients
- Remote follow-up coordination for patients returning to their home countries
Get in Touch
If you have liver cancer or another hepatobiliary malignancy and are interested in integrating Traditional Chinese Medicine into your treatment plan in Shanghai, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commenti